Results 1 - 10 of 1199

< 1 2 3 ... 119 120 >

• HPLC of Hydromorphone on Phenomenex Synergi 4u Hydro-RP 80A with UV detection
• Gaik B. Kok and Peter J. Scammells. Improved synthesis of 14-hydroxy opioid pharmaceuticals and intermediates, RSC Advances, 2012, 2, 11318.

  [DOI: 10.1039/c2ra21693k]
  
• Zorrilla Eric P., Heilig Markus, de Wit Harriet, Shaham Yavin. Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism, Drug and Alcohol Dependence, 2013

  [DOI: 10.1016/j.drugalcdep.2012.12.0]
  
• Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction., The Clinical journal of pain

  [PubMed: 22156893]
  [DOI: 10.1097/AJP.0b013e318237d626]
  
• Carr DB; McDonnell Moorehead T; Bouchard A; Sprenger CR; Hamilton DA; Lang E; Madden D; Lacouture PG; Wright C 4th. Effects of injectable HP?CD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo., Clinical therapeutics

  [PubMed: 23578606]
  [DOI: 10.1016/j.clinthera.2013.03.01]
  
• Yee B; Killick R; Wong K. Restless legs syndrome., Australian family physician

  [PubMed: 19458798]
  
• O'Hare E; Kim EM; Page D; Reid R. Effects of thyroxine treatment on histology and behavior using the methimazole model of congenital hypothyroidism in the rat., Neuroscience

  [PubMed: 25446345]
  [DOI: 10.1016/j.neuroscience.2014.11]
  
• McCarthy DE; Ebssa L; Witkiewitz K; Shiffman S. Repeated measures latent class analysis of daily smoking in three smoking cessation studies., Drug and alcohol dependence

  [PubMed: 27317043]
  [DOI: 10.1016/j.drugalcdep.2016.05.0]
  
• Chen DL; Li YH; Wang ZJ; Zhu YK. The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain., Medicine

  [PubMed: 27759644]
  [DOI: 10.1097/MD.0000000000005144]
  
• Yin K; Deuis JR; Lewis RJ; Vetter I. Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target., Molecular pain

  [PubMed: 27573516]
  [DOI: 10.1177/1744806916665366]